Authors: SEIBOLD JR KORN J SIMMS R CLEMENTS PJ MORELAND L MAYES MD FURST DE ROTHFIELD N STEEN V WEISMAN M DEMARCO P COLLIER D WIGLEY F MERKEL PA CSUKA ME ROCCO S ERIKSON M HANNIGAN J HARKONEN WS SANDERS ME

Citation: Jr. Seibold et al., CONTROLLED TRIAL OF RECOMBINANT HUMAN RELAXIN (RHRLXN) IN DIFFUSE SCLERODERMA (DS), Arthritis and rheumatism, 40(9), 1997, pp. 557-557

Authors: ZUNICH KM HARKONEN WS WOLOSKI M KINGSBURY L

Citation: Km. Zunich et al., INTRAVENOUS ANTI-D IMMUNOGLOBULIN FOR CHILDHOOD ACUTE IMMUNE THROMBOCYTOPENIC PURPURA, Lancet, 346(8986), 1995, pp. 1363-1364

Authors: PIER GB DESJARDIN D GROUT M GARNER C BENNETT SE PEKOE G FULLER SA THORNTON MO HARKONEN WS MILLER HC

Citation: Gb. Pier et al., HUMAN IMMUNE-RESPONSE TO PSEUDOMONAS-AERUGINOSA MUCOID EXOPOLYSACCHARIDE (ALGINATE) VACCINE, Infection and immunity, 62(9), 1994, pp. 3972-3979

Authors: ZUNICH KM HARKONEN WS WOLOSKI M BUSSEL JB

Citation: Km. Zunich et al., RH(C)(D) IMMUNE GLOBULIN INTRAVENOUS IN PATIENTS WITH ITP AND HISTORYOF PRIOR TREATMENT WITH INTRAVENOUS IMMUNE GLOBULIN AND OR CORTICOSTEROIDS, Blood, 84(10), 1994, pp. 10000187-10000187

Authors: ZUNICH KM HARKONEN WS HAFKIN B TITUS C GARNER D WOLOSKI M

Citation: Km. Zunich et al., A DOSE-RANGING EVALUATION OF THE EFFECT OF A SINGLE ADMINISTRATION OFRH0(D) IMMUNE GLOBULIN INTRAVENOUS IN HEALTHY-VOLUNTEERS, Blood, 84(10), 1994, pp. 10000664-10000664

Authors: HARKONEN WS GREGG KA

Citation: Ws. Harkonen et Ka. Gregg, BACK TO THE FUTURE WITH POLYCLONAL ANTIBODIES, Bio/technology, 11(13), 1993, pp. 1518-1518